SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-004990
Filing Date
2023-02-14
Accepted
2023-02-14 16:35:32
Documents
1
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 13864
  Complete submission text file 0000899243-23-004990.txt   15075
Mailing Address
Business Address
MILNE GEORGE M JR (Reporting) CIK: 0001179552 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-41199 | Film No.: 23630403

Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Issuer) CIK: 0001658551 (see all company filings)

IRS No.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations